Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17446657rdf:typepubmed:Citationlld:pubmed
pubmed-article:17446657lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:17446657lifeskim:mentionsumls-concept:C1621895lld:lifeskim
pubmed-article:17446657lifeskim:mentionsumls-concept:C0025876lld:lifeskim
pubmed-article:17446657lifeskim:mentionsumls-concept:C0221406lld:lifeskim
pubmed-article:17446657lifeskim:mentionsumls-concept:C1134488lld:lifeskim
pubmed-article:17446657lifeskim:mentionsumls-concept:C0439234lld:lifeskim
pubmed-article:17446657lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:17446657lifeskim:mentionsumls-concept:C1709630lld:lifeskim
pubmed-article:17446657lifeskim:mentionsumls-concept:C0522501lld:lifeskim
pubmed-article:17446657pubmed:issue3lld:pubmed
pubmed-article:17446657pubmed:dateCreated2007-7-20lld:pubmed
pubmed-article:17446657pubmed:abstractTextA 66-year-old woman had massive bilateral adrenal macronodular hyperplasia, found incidentally on an abdominal ultrasonogram. Her plasma ACTH and serum cortisol levels were normal, but they were not suppressed by low-dose dexamethasone. The patient did not exhibit any typical signs or symptoms of Cushing's disease. MRI showed no evidence of a tumor in the pituitary gland. A diagnosis of preclinical Cushing's disease was made, and she was treated with 11-hydroxylase inhibitor metyrapone. As the dose of metyrapone was increased, plasma ACTH levels gradually increased. After three years of treatment, she developed moon-face. Her plasma ACTH and serum cortisol concentrations were at their highest levels. A pituitary microadenoma was detected by MRI, whose source of ACTH was demonstrated by the definite step-up of central/peripheral ratio of ACTH obtained by cavernous sinus sampling. Overt Cushing's disease was diagnosed, and a pituitary tumor was removed by transsphenoidal surgery. In conclusion, the clinically and endocrinologically overt Cushing's disease characterized by macronodular adrenal hyperplasia was converted from a preclinical form. This case offers some insight into the clinical and biological features of preclinical Cushing's disease.lld:pubmed
pubmed-article:17446657pubmed:languageenglld:pubmed
pubmed-article:17446657pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17446657pubmed:citationSubsetIMlld:pubmed
pubmed-article:17446657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17446657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17446657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17446657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17446657pubmed:statusMEDLINElld:pubmed
pubmed-article:17446657pubmed:monthJunlld:pubmed
pubmed-article:17446657pubmed:issn0918-8959lld:pubmed
pubmed-article:17446657pubmed:authorpubmed-author:NomuraKaoruKlld:pubmed
pubmed-article:17446657pubmed:authorpubmed-author:TakanoKazueKlld:pubmed
pubmed-article:17446657pubmed:authorpubmed-author:OhmoriNarikoNlld:pubmed
pubmed-article:17446657pubmed:authorpubmed-author:OhmoriKazueKlld:pubmed
pubmed-article:17446657pubmed:issnTypePrintlld:pubmed
pubmed-article:17446657pubmed:volume54lld:pubmed
pubmed-article:17446657pubmed:ownerNLMlld:pubmed
pubmed-article:17446657pubmed:authorsCompleteYlld:pubmed
pubmed-article:17446657pubmed:pagination391-7lld:pubmed
pubmed-article:17446657pubmed:meshHeadingpubmed-meshheading:17446657...lld:pubmed
pubmed-article:17446657pubmed:meshHeadingpubmed-meshheading:17446657...lld:pubmed
pubmed-article:17446657pubmed:meshHeadingpubmed-meshheading:17446657...lld:pubmed
pubmed-article:17446657pubmed:meshHeadingpubmed-meshheading:17446657...lld:pubmed
pubmed-article:17446657pubmed:meshHeadingpubmed-meshheading:17446657...lld:pubmed
pubmed-article:17446657pubmed:meshHeadingpubmed-meshheading:17446657...lld:pubmed
pubmed-article:17446657pubmed:meshHeadingpubmed-meshheading:17446657...lld:pubmed
pubmed-article:17446657pubmed:meshHeadingpubmed-meshheading:17446657...lld:pubmed
pubmed-article:17446657pubmed:meshHeadingpubmed-meshheading:17446657...lld:pubmed
pubmed-article:17446657pubmed:meshHeadingpubmed-meshheading:17446657...lld:pubmed
pubmed-article:17446657pubmed:meshHeadingpubmed-meshheading:17446657...lld:pubmed
pubmed-article:17446657pubmed:meshHeadingpubmed-meshheading:17446657...lld:pubmed
pubmed-article:17446657pubmed:year2007lld:pubmed
pubmed-article:17446657pubmed:articleTitlePreclinical Cushing's disease characterized by massive adrenal hyperplasia and hormonal changes after three years of metyrapone therapy.lld:pubmed
pubmed-article:17446657pubmed:affiliationDepartment of Medicine, Institute of Clinical Endocrinology, Tokyo, Japan.lld:pubmed
pubmed-article:17446657pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17446657pubmed:publicationTypeCase Reportslld:pubmed